| Project Detail |
The worlds first refillable insulin pen
Approximately 22 % or 13 million people with diabetes currently rely on syringes to inject insulin due to the high cost of insulin pens. Funded by the European Innovation Council, the GO-Pen project aims to create a safe and affordable refillable insulin pen that can be used with any insulin type. This innovative solution will provide more precise dosing, undergo clinically tested design, and be more user-friendly for diabetic patients. The projects ultimate goal is to produce this insulin delivery system at scale, making it widely available to enhance the quality of life of millions of individuals living with diabetes worldwide. By promoting accessibility and affordability, GO-Pen will contribute to global health equity, allowing more people to manage their diabetes effectively and live healthier, more fulfilling lives.
The challenge for many people with diabetes (PwD) is that they don’t get the right dose of insulin at the right time. This can potentially give long term health issues, and even shorten their lifetime. Today, this is an everyday challenge for more than 13 million people that still inject insulin with a 100 year’s old outdated technology (syringes and needles) and cannot afford branded insulin and modern pens. GO-Pen ApS developed the 1st affordable, safe, and sustainable insulin injection system that fits the unmet health needs in the world’s most resource constrained population. The UNIPEN system innovation relies on the possibility of refilling a disposable cartridge with any kind of insulin available, resulting in a cost-competitive device to syringes solution improving the accuracy. Now, with the support of the EIC-A funding, we intend to refine the design of the UNIPEN device, demonstrate its design and clinical usability, and fine-tune the scale-up production. |
